Drug shortage
Nitrofurantoin Oral Suspension · Amneal Pharmaceuticals
FDA drug shortage · To Be Discontinued · updated Apr 10, 2026
Key facts
| Generic name | Nitrofurantoin Oral Suspension |
|---|---|
| Company | Amneal Pharmaceuticals |
| Presentation | Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9) |
| Dosage form | Oral Suspension |
| Status | To Be Discontinued |
| Therapeutic category | Anti-Infective Other |
| Package NDCs | 69238-2512-9 |
| First posted | Apr 10, 2026 |
| Last updated | Apr 10, 2026 |
| Discontinued | Apr 10, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: